[1] |
TsiatisAA, DafniU, DeGruttolaV, PropertKJ, StrawdermanRL, WulfsohnM. The relationship of CD4 counts over time to survival in patients with AIDS: Is CD4 a good surrogate marker? In: JewellNP (ed.), DietzK (ed.), FarewellVT (ed.), eds. AIDS Epidemiology. Vol 73. Boston, MA: Birkhäuser; 1992:256‐274. |
[2] |
deGruttolaV, TuX. Modelling progression of CD4‐lymphocyte count and its relationship to survival time. Biometrics. 1994;50:1003‐1014. · Zbl 0825.62792 |
[3] |
CoxD. Regression models and life‐tables. J Royal Stat Soc Ser B. 1972;34:187‐220. · Zbl 0243.62041 |
[4] |
BrownER, IbrahimJG. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. Biometrics. 2003;59:221‐228. · Zbl 1210.62022 |
[5] |
IbrahimJG, ChenMH, SinhaDY. Bayesian methods for joint modeling of longitudinal and survival data with applications to cancer vaccine trials. Stat Sin. 2004;14:863‐883. · Zbl 1073.62100 |
[6] |
BarrettJ, SuL. Dynamic prediction using flexible joint models of longitudinal and time‐to‐event data. Stat Med. 2017;36:1447‐1460. |
[7] |
AndrinopoulouE, EilersPH, TakkenbergJJ, RizopoulosD. Improved dynamic prediction from joint models of longitudinal and survival data with time‐varying effects using P‐splines. Biometrics. 2018;74:685‐693. · Zbl 1414.62429 |
[8] |
HashemiR, Jacqmin‐GaddaH, CommengesD. A latent process model for joint modeling of events and marker. Lifetime Data Anal. 2003;9:331‐343. · Zbl 1038.62074 |
[9] |
Jacqmin‐GaddaH, CommengesD, DartiguesJF. Random change point model for joint modeling of cognitive decline and dementia. Biometrics. 2006;62:254‐260. · Zbl 1091.62134 |
[10] |
LiK, LuoS. Functional joint model for longitudinal and time‐to‐event data: an application to Alzheimer’s disease. Stat Med. 2017;36:3560‐3572. |
[11] |
HastieT, TibshiraniR, FriedmanJ. The Elements of Statistical Learning: Data Mining, Inference and Prediction. 2nd ed.New York, NY: Springer; 2009. · Zbl 1273.62005 |
[12] |
GuoR, ZhuH, ChowS, IbrahimJG. Bayesian lasso for semiparametric structural equation models. Biometrics. 2012;68:567‐577. · Zbl 1274.62781 |
[13] |
KangK, SongXY, HuXJ, ZhuHT. Bayesian hidden Markov models for delineating the pathology of Alzheimer’s disease. Stat Med. 2019;38:1634‐1650. |
[14] |
LangS, BrezgerA. Bayesian P‐splines. J Comput Graph Stat. 2004;13:183‐212. |
[15] |
SongXY, LuZH. Semiparametric latent variable models with Bayesian P‐splines. J Comput Graph Stat. 2010;19:590‐608. |
[16] |
LeeEJ, ZhuHT, KongDH, WangYL, GiovanelloKS, IbrahimJG. BFLCRM: A Bayesian functional linear Cox regression model for predicting time to conversion to Alzheimer’s disease. Ann Appl Stat. 2015;9:2153‐2178. · Zbl 1397.62456 |
[17] |
KongDH, IbrahimJG, LeeEJ, ZhuHT. FLCRM: functional linear Cox regression model. Biometrics. 2018;74:109‐117. · Zbl 1415.62111 |
[18] |
SammelM, RyanL. Latent variable models with fixed effects. Biometrics. 1996;52:650‐663. · Zbl 0875.62248 |
[19] |
RoyJ, LinXH. Latent variable models for longitudinal data with multiple continuous outcomes. Biometrics. 2000;56:1047‐1054. · Zbl 1060.62565 |
[20] |
PanD, HeHJ, SongXY, SunLQ. Regression analysis of additive hazards model with latent variables. J Am Stat Assoc. 2015;110:1148‐1159. · Zbl 1373.62480 |
[21] |
PanD, KangK, WangCJ, SongXY. Bayesian proportional hazards model with latent variables. Stat Methods Med Res. 2019;28:986‐1002. |
[22] |
HeHJ, PanD, SongXY, SunLQ. Additive mean residual life model with latent variables under right censoring. Stat Sin. 2019;29:47‐66. · Zbl 1412.62150 |
[23] |
SongXY, LeeSY. Basic and Advanced Bayesian Structural Equation Modeling: With Applications in the Medical and Behavioral Sciences. London, UK: Wiley; 2012. · Zbl 1282.62056 |
[24] |
IbrahimJG, ChenMH, SinhaD. Bayesian Survival Analysis. New York, NY: Springer‐Verlag; 2001. · Zbl 0978.62091 |
[25] |
YinG, IbrahimJG. A general class of Bayesian survival models with zero and nonzero cure fractions. Biometrics. 2005;61:403‐412. · Zbl 1077.62087 |
[26] |
PanD, WeiYY, SongXY. Joint analysis of mixed types of outcomes with latent variables. Stat Med. 2021;40:1272‐1284. |
[27] |
RosenbergPS. Hazard function estimation using B‐splines. Biometrics. 1995;51:874‐887. · Zbl 0875.62489 |
[28] |
YounesN, LachinJ. Link‐based models for survival data with interval and continuous time censoring. Biometrics. 1997;53:1199‐1211. · Zbl 0911.62113 |
[29] |
ZhouXX, SongXY. Mediation analysis for mixture Cox proportional hazards cure models. Stat Methods Med Res. 2021;30:1554‐1572. |
[30] |
CoxDR, HinkleyDV. Theoretical Statistics. London, UK: Chapman & Hall; 1974. · Zbl 0334.62003 |
[31] |
HeagertyPJ, ZhengYY. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92‐105. · Zbl 1077.62077 |
[32] |
RizopoulosD. Dynamic prediction and prospective accuracy in joint models for longitudinal and time‐to‐event data. Biometrics. 2011;67:819‐829. · Zbl 1226.62124 |
[33] |
LiTF, XieFC, FengXN, IbrahimJG, ZhuHT. Functional linear regression models for nonignorable missing scalar responses. Stat Sin. 2018;28:1867‐1886. · Zbl 1406.62140 |
[34] |
MohsRC, KnopmanD, PetersenRC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s disease assessment scale that broaden its scope. Alzheimer Dis Assoc Disord. 1997;11:S13‐S21. |
[35] |
OkuizumiK, OnoderaO, TanakaH, et al. ApoE‐\( \epsilon 4\) and early‐onset Alzheimer’s. Nat Genet. 1994;7:10‐11. |
[36] |
JöreskogKG, SörbomD. LISREL 8: Structural Equation Modeling with the SIMPLIS Command Language. Scientific Software International; 1996. |
[37] |
HelmerC, DamonD, LetenneurL, et al. Marital status and risk of Alzheimer’s disease: a French population‐based cohort study. Neurology. 1999;53:1953‐1958. |
[38] |
CorderEH, SaundersAM, StrittmatterWJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921‐923. |
[39] |
SaundersAM, StrittmatterWJ, SchmechelD, et al. Association of apolipoprotein E allele \(\epsilon 4\) with late‐onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467‐1472. |
[40] |
PodcasyJL, EppersonCL. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci. 2016;18:437‐446. |
[41] |
ViñaJ, LloretA. Why women have more Alzheimer’s disease than men: gender and mitochondrial toxicity of amyloid‐\( \beta\) peptide. J Alzheimers Dis. 2010;20:S527‐S533. |
[42] |
ChenP, RatcliffG, BelleSH, CauleyJA, DekoskyST, GanguliM. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry. 2001;58:853‐858. |
[43] |
CloutierS, ChertkowH, KergoatM, GauthierS, BellevilleS. Patterns of cognitive decline prior to dementia in persons with mild cognitive impairment. J Alzheimers Dis. 2015;47:901‐913. |
[44] |
BirksJ. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006;CD005593. 1. |
[45] |
NealM, BartonWP. Validation therapy for dementia. Cochrane Database Syst Rev. 2003;3:CD001394. |
[46] |
KutnerMH, NachtsheimCJ, NeterJ. Applied Linear Regression. 4th ed.New York, NY: McGraw‐Hill/Irwin Series; 2004. |
[47] |
WeissNA. Introductory Statistics. 10th ed.Boston, MA: Pearson; 2012. |
[48] |
EscobarM. Estimating normal means with a Dirichlet process prior. J Am Stat Assoc. 1994;89:268‐277. · Zbl 0791.62039 |
[49] |
GrambschPM, TherneauTM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515‐526. · Zbl 0810.62096 |